Barbara A. Weir

44.3k total citations · 1 hit paper
46 papers, 4.1k citations indexed

About

Barbara A. Weir is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Barbara A. Weir has authored 46 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 12 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Barbara A. Weir's work include Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (6 papers) and Genomic variations and chromosomal abnormalities (6 papers). Barbara A. Weir is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (6 papers) and Genomic variations and chromosomal abnormalities (6 papers). Barbara A. Weir collaborates with scholars based in United States, Australia and Japan. Barbara A. Weir's co-authors include Matthew Meyerson, Rameen Beroukhim, Travis Zack, William C. Hahn, D. W. Sundstrom, David Pellman, Gad Getz, Wendy Winckler, Scott L. Carter and Eric S. Lander and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Barbara A. Weir

45 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Absolute quantification of somatic DNA alterations in human cancer

2012 1.1k citations Scott L. Carter, Travis Zack et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara A. Weir United States	29	2.4k	1.4k	1.0k	879	553	46	4.1k
Bernard W. Futscher United States	43	3.6k 1.5×	1.1k 0.8×	1.2k 1.1×	271 0.3×	599 1.1×	91	4.9k
Yutaka Midorikawa Japan	31	1.7k 0.7×	729 0.5×	689 0.7×	388 0.4×	211 0.4×	110	3.4k
Eiju Tsuchiya Japan	49	3.5k 1.5×	1.5k 1.0×	2.0k 1.9×	1.8k 2.0×	516 0.9×	123	6.4k
Alex Soltermann Switzerland	44	1.9k 0.8×	782 0.6×	2.2k 2.1×	1.6k 1.9×	180 0.3×	170	5.1k
W. David Henner United States	43	2.9k 1.2×	1.0k 0.7×	1.9k 1.8×	988 1.1×	509 0.9×	95	5.5k
Michael O’Dwyer Ireland	40	2.0k 0.8×	272 0.2×	983 0.9×	187 0.2×	125 0.2×	162	4.3k
Pengda Liu United States	35	3.4k 1.4×	670 0.5×	996 1.0×	471 0.5×	176 0.3×	79	4.7k
Mohammad R. Akbari Canada	29	1.3k 0.5×	1.1k 0.8×	1.0k 1.0×	351 0.4×	1.1k 1.9×	133	3.3k
Martin R. Sprick Germany	31	4.0k 1.7×	2.0k 1.4×	3.6k 3.5×	438 0.5×	391 0.7×	58	6.6k
De‐Shen Wang China	40	2.9k 1.2×	2.5k 1.8×	2.0k 1.9×	1.4k 1.6×	234 0.4×	142	6.2k

Countries citing papers authored by Barbara A. Weir

Since Specialization

Citations

This map shows the geographic impact of Barbara A. Weir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara A. Weir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara A. Weir more than expected).

Fields of papers citing papers by Barbara A. Weir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara A. Weir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara A. Weir. The network helps show where Barbara A. Weir may publish in the future.

Co-authorship network of co-authors of Barbara A. Weir

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara A. Weir. A scholar is included among the top collaborators of Barbara A. Weir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara A. Weir. Barbara A. Weir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hsu, Jessie Hao-Ru, Guillaume Adelmant, Jialiang Huang, et al.. (2017). PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer. Cancer Research. 77(17). 4613–4625. 26 indexed citations

Gannon, Hugh, Nathan O. Kaplan, Aviad Tsherniak, et al.. (2015). Identification of an “Exceptional Responder” Cell Line to MEK1 Inhibition: Clinical Implications for MEK-Targeted Therapy. Molecular Cancer Research. 14(2). 207–215. 19 indexed citations

Luo, Leo Y., Eejung Kim, Hiu Wing Cheung, et al.. (2014). The Tyrosine Kinase Adaptor Protein FRS2 Is Oncogenic and Amplified in High-Grade Serous Ovarian Cancer. Molecular Cancer Research. 13(3). 502–509. 29 indexed citations

Etemadmoghadam, Dariush, George Au‐Yeung, Meaghan Wall, et al.. (2013). Resistance to CDK2 Inhibitors Is Associated with Selection of Polyploid Cells in CCNE1 -Amplified Ovarian Cancer. Clinical Cancer Research. 19(21). 5960–5971. 90 indexed citations

Etemadmoghadam, Dariush, Barbara A. Weir, George Au‐Yeung, et al.. (2013). Synthetic lethality between CCNE1 amplification and loss of BRCA1. Proceedings of the National Academy of Sciences. 110(48). 19489–19494. 157 indexed citations

Sulahian, Rita, Fergal Casey, Jie Shen, et al.. (2013). An integrative analysis reveals functional targets of GATA6 transcriptional regulation in gastric cancer. Oncogene. 33(49). 5637–5648. 48 indexed citations

Ren, Yin, Hiu Wing Cheung, Amit Agrawal, et al.. (2012). Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4. Science Translational Medicine. 4(147). 147ra112–147ra112. 134 indexed citations

Nijhawan, Deepak, Travis Zack, Yin Ren, et al.. (2012). Cancer Vulnerabilities Unveiled by Genomic Loss. Cell. 150(4). 842–854. 161 indexed citations

Ren, Yin, Amit Agrawal, Jill P. Mesirov, et al.. (2012). Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Target ID4. DSpace@MIT (Massachusetts Institute of Technology). 2 indexed citations

10.

Shao, Diane D., Aviad Tsherniak, Shuba Gopal, et al.. (2012). ATARiS: Computational quantification of gene suppression phenotypes from multisample RNAi screens. Genome Research. 23(4). 665–678. 78 indexed citations

11.

Cheung, Hiu Wing, Jinyan Du, Jesse S. Boehm, et al.. (2011). Amplification of CRKL Induces Transformation and Epidermal Growth Factor Receptor Inhibitor Resistance in Human Non–Small Cell Lung Cancers. Cancer Discovery. 1(7). 608–625. 110 indexed citations

12.

Shrestha, Yashaswi, Eric J. Schafer, Jesse S. Boehm, et al.. (2011). PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling. Oncogene. 31(29). 3397–3408. 124 indexed citations

13.

Barletta, Justine A., Sven Perner, A. John Iafrate, et al.. (2008). Clinical significance of TTF‐1 protein expression and TTF‐1 gene amplification in lung adenocarcinoma. Journal of Cellular and Molecular Medicine. 13(8b). 1977–1986. 82 indexed citations

14.

Minami, Yuko, Takeshi Shimamura, Kinjal Shah, et al.. (2007). The major lung cancer-derived mutants of ERBB2 are oncogenic and are associated with sensitivity to the irreversible EGFR/ERBB2 inhibitor HKI-272. Oncogene. 26(34). 5023–5027. 88 indexed citations

15.

Zhao, Xiaojun, Barbara A. Weir, Thomas LaFramboise, et al.. (2005). Homozygous Deletions and Chromosome Amplifications in Human Lung Carcinomas Revealed by Single Nucleotide Polymorphism Array Analysis. Cancer Research. 65(13). 5561–5570. 242 indexed citations

16.

Weir, Barbara A. & Michael P. Yaffe. (2004). Mmd1p, a Novel, Conserved Protein Essential for Normal Mitochondrial Morphology and Distribution in the Fission YeastSchizosaccharomyces pombe. Molecular Biology of the Cell. 15(4). 1656–1665. 42 indexed citations

17.

Weir, Barbara A., Xiaojun Zhao, & Matthew Meyerson. (2004). Somatic alterations in the human cancer genome. Cancer Cell. 6(5). 433–438. 120 indexed citations

18.

Bertani, L. Elizabeth, et al.. (1997). Evidence for two types of subunits in the bacterioferritin of Magnetospirillum magnetotacticum. Gene. 201(1-2). 31–36. 24 indexed citations

19.

Weir, Barbara A., D. W. Sundstrom, & Herbert E. Klei. (1987). Destruction of Benzene by Ultraviolet Light-Catalyzed Oxidation with Hydrogen Peroxide. Hazardous Waste and Hazardous Materials. 4(2). 165–176. 31 indexed citations

20.

Sundstrom, D. W., et al.. (1986). Destruction of Halogenated Aliphatics by Ultraviolet Catalyzed Oxidation with Hydrogen Peroxide. Hazardous Waste and Hazardous Materials. 3(1). 101–110. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact